Wells Fargo’s Nanobiotix NBTX Stock Holding History

Wells Fargo’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.17K	Hold	200	–	–	﹤0.01%	6071
2025 Q4	$4.62K	Buy	+200	New	+$4.37K	﹤0.01%	6116

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Wells Fargo's NBTX Position: Q1 2026 in Review

Wells Fargo held its Nanobiotix (NBTX) position steady in Q1 2026 at 200 shares worth $6.17K. The position accounts for ﹤0.01% of the portfolio, ranked #6071.

Wells Fargo first reported a position in NBTX in Q4 2025 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold NBTX as of Q1 2026.

Wells Fargo held 200 shares of Nanobiotix worth $6.17K as of Q1 2026.
Wells Fargo left its Nanobiotix share count unchanged in Q1 2026.
Nanobiotix made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6071 holding.
Wells Fargo first reported a position in Nanobiotix in Q4 2025 and has held it in 2 quarters since.
15 funds tracked by Wall St. Rank held Nanobiotix as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.